DARE - Dare Bioscience, Inc.
1.53
-0.040 -2.614%
Share volume: 57,324
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$1.57
-0.04
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-12-2024 | 11-14-2024 | 05-13-2025 | 08-14-2025 | 11-13-2025 | |
| Cash flow financing | 14.032 K | 115.366 K | 436.444 K | 246.577 K | -43.794 K | 18.650 M | |
| Other financing cash flows | -690.000 | -815.000 | -405.000 | -2.450 K | -456.400 K | -458.850 K | |
| Cash flow | -6.806 M | 12.735 M | -5.205 M | -5.381 M | -5.308 M | 18.033 M | |
| Net income | -6.755 M | 12.911 M | -4.703 M | -4.378 M | -4.016 M | -3.563 M | |
| Depreciation | 10.778 K | 15.437 K | 9.742 K | 158.110 K | 460.075 K | 481.906 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 436.461 K | 0.000 | 0.000 | -124.748 K | 0.000 | 0.000 | |
| Investing Cashflow | -7.296 K | -285.226 K | 282.325 K | -157.331 K | 153.396 K | -174.702 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 7.296 K | 285.226 K | -282.325 K | 157.331 K | -153.396 K | 174.702 K | |
| Cash Change | -6.845 M | 12.749 M | -5.182 M | -5.368 M | -5.295 M | 18.040 M |